The 0.01 mg/kg dose showed a trend towards dose:reference interaction ( P =0.072), where a positive slope indicates that 0.01 mg/kg SCH worsens performance in low-d’ mice and improved performance in high-d’ mice. %Acc was significantly increased by 0.02 ( P <0.01) and 0.04 mg/kg SCH ( P <0.001), and a trend effect was seen at 0.01 mg/kg ( P =0.055).
Low V̇O 2 –High VAT young adult males and females showed a trend toward an increase of production of TNF‐α ( p ‐value = 0.072, p ‐value adjusted 1 = 0.096, and p ‐value adjusted 2 = 0.536) compared with the absence of LPS.
Specifically, higher peak behavioral response showed a trend for a positive association with the degree of right middle temporal region (F = 3.5, P = 0.072).
Craniopharyngioma histology showed a trend toward higher mortality (aOR 3.5, 95% CI 0.9-13.9, p=0.072) but did not reach statistical significance.
Regarding treatment and response, nCRT with TRG 0–1 showed a trend toward improved DFS compared with direct surgery (HR, 0.56; 95% CI, 0.29–1.06; P = 0.072), while nCRT with TRG 2 or TRG 3 did not significantly influence DFS.
Age showed a trend toward a negative effect on pain ( p = 0.072), while compression force showed a trend toward a positive effect ( p = 0.067).
The 2-year cumulative incidence of severe cGVHD in the ATG/PTCy group showed a trend toward decrease compared to that in the ATG group (6.3% vs. 28.4%, P = 0.072).
In the multivariate Cox regression analysis adjusted for age, ECOG PS, histology, disease stage, PD‐L1 status, presence of metastases and treatment regimen, the association with OS remained significant (adjusted HR: 1.539, 95% confidence interval [CI]: [1.156–2.048], p = 0.003), whereas PFS showed a trend toward shorter survival that did not reach statistical significance (adjusted HR: 1.253, 95% CI: [0.980–1.602], p = 0.072) (Table 2 ).
Compared to the self-disciplined group, the passive group showed significantly increased risks of overweight (OR = 1.62, 95% CI: 1.02–2.57) and obesity (OR = 1.68, 95% CI: 1.13–2.50), while the high-risk group showed a trend toward increased obesity risk (OR = 1.57, 95% CI: 0.96–2.57, P = 0.072).
At 6 months, radiographic healing showed a trend towards better union in the Parachute Technique group (9.00 ± 0.73 vs. 8.60 ± 0.59, p = 0.072).
A second multiple regression model including the CAARMS thought content, perceptual abnormalities, and disorganized speech subscales showed a trend toward significance overall [ F (3,13) = 2.949, P = .072], with only the thought content subscale showing a trend toward predicting SAT explicit aberrant salience ( t = 2.0, P = .075).
Additionally, high RAB39B expression was correlated with higher BM blast counts ( P = 0.012) and showed a trend toward correlation with higher peripheral blood (PB) blast counts ( P = 0.072) and white blood cell (WBC) counts ( P = 0.060).
In addition, age ≥90 y showed a trend toward association with the occurrence of postoperative complications (OR: 1.64, 95% CI: 0.96–2.80, p = 0.072).
ViV showed a trend towards higher 1-year mortality (HR 1.2; 95% CI, 0.98–1.44; P = 0.072), which became significant after multivariate adjustment (adjusted HR 1.26; 95% CI 1.03–1.56; P = 0.028) ( Figure 3C ).
This medication showed a trend for risks to cataract (HR = 1.90, p = 0,072), tear film insufficiency (HR = 2.65, p = 0.071) in the survival analyses, which require further validation in both short-term and long-term prospective trials.
The suboptimal group showed a trend towards a higher incidence of MALE than the optimal group (log-rank p = 0.072).
Although not statistically significant, GTR also showed a trend toward greater radiographic bone fill compared to GBR (78.5% vs. 75.2%, P = 0.072).
Notably, predialysis urine output showed a trend toward higher values in the control group (844.9 ± 548.1 vs 653.1 ± 494.6 mL, p =0.072, SMD = 0.367), though this did not reach statistical significance.
IL‐1β showed a trend at 1 h (2.197 ± 0.474 vs 4.512 ± 0.139, p = 0.072) and was significantly higher at 6 h (2.525 ± 0.199 vs 6.416 ± 0.258, p = 0.0090) and 24 h (2.433 ± 0.061 vs 6.839 ± 0.004, p = 0.0090).
1.8 mm) showed a trend toward association, with thinner wires being more likely to lead to backout (OR: 5.08, 95% CI: 0.86-29.9; p = 0.072); however, this relationship was not statistically significant (Table 3 ).
In multivariable Cox regression analysis adjusting for age, sex, CCI, LVEF, and AVA (Table 3 ), grade 3 AI‐enabled electrocardiography DD was independently associated with increased mortality risk (HR, 1.80 [95% CI, 1.47–2.20]; P <0.001), whereas moderate DD (grade 2) showed a trend toward higher risk (HR, 1.19 [95% CI, 0.99–1.43]; P =0.072).
When analyzed by tumor volume, small-sized tumors (less than 1 mL) showed a trend of longer PFS without symptomatic radiation necrosis when the prescription dose was increased up to 24 Gy ( p =0.072).
They also showed a trend toward lower chance of progressive disease in the LN5High group [1 out of 28 (LN5high) vs 17 out of 69 (LN5low); P = 0.072).
In multivariate cox regression analysis SMO expression showed a trend towards an independent predictor for shorter overall survival (HR = 0.57; 95% CI = 0.30–1.05; P = 0.072) and disease‐free survival (HR = 0.53; 95% CI = 0.28–1.02; P = 0.056).
β-diversity analysis showed a trend towards different bacterial communities ( p = 0.072).